Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.
Journal: The New England journal of medicine
Published: April 08, 2024
Vasopressin mediates fructose-induced metabolic syndrome by activating the V1b receptor.
Journal: JCI insight
Published: June 02, 2020
Under-reporting of adverse effects of tesofensine.
Journal: Lancet (London, England)
Published: July 16, 2013
Showing 1-3 of 3
Last Updated: 09/26/2026